Table of Contents
Historical Data, Premium Insights, Market Dynamic, Analysis and Projection, By Product, Analysis and Projection, By Application, Analysis and Projection, By End-Use, Analysis and Projection, By Regional Analysis, Competitive Landscape, Company Profiles, Market Revenue, Sale & Price Analysis
Related Topics
Pet Mobility Aids Market Size Surgical Loupes and Cameras Market Size Aluminum Extrusion Market Size High Performance Adhesives Market SizeGlobal Animal Gastroesophageal Reflux Disease Market Size to worth USD 6.53 Billion by 2033
According to a research report published by Spherical Insights & Consulting, the Global Animal Gastroesophageal Reflux Disease Market Size is Expected to Grow from USD 3.09 Billion in 2023 to USD 6.53 Billion by 2033, at a CAGR of 7.77% during the forecast period 2023-2033.
Browse key industry insights spread across 210 pages with 110 Market data tables and figures & charts from the report on the Global Animal Gastroesophageal Reflux Disease Market Size, Share, and COVID-19 Impact Analysis, By Product (Diagnostics, Treatment, and Others), By Animal (Companion Animal and Livestock Animal), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.
Animal gastroesophageal reflux disease is a diagnosis, treatment, and management of GERD in animals; this is when the stomach acid flows backward to the esophagus, bringing about discomfort and possible complications. The market encompasses pharmaceuticals, dietary management solutions, diagnostic tools, and veterinary care services addressing GERD in companion animals and livestock. The growth of the market is largely due to the increasing prevalence of digestive disorders in animals, growing animal health awareness, and the trend of increasing pets worldwide. Emphasis on preventive veterinary care along with advances in diagnostic technologies have pushed the demand for effective GERD treatments. Pet humanization, along with an owner's desire to spend a lot on state-of-the-art healthcare solutions, also fuels this market. However, market growth may be limited by the high cost of diagnostic procedures, low awareness of GERD symptoms among pet owners, and the lack of standardized treatment protocols for animals.
The treatment segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period.
Based on the product, the animal gastroesophageal reflux disease market is classified into diagnostics, treatment, and others. Among these, the treatment segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period. The dominance of the treatment segment is attributed to the increasing demand for effective therapies to manage and alleviate the symptoms of GERD in animals. Various treatment options, including antacids, proton pump inhibitors, and prokinetic agents, are commonly prescribed to control acid reflux and prevent esophageal damage. The growing awareness of the importance of managing GERD symptoms in both companion animals and livestock further fuels the demand for these therapeutic solutions.
The companion animals segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period.
Based on the animal, the animal gastroesophageal reflux disease market is divided into companion animals and livestock animals. Among these, the companion animals segment accounted for the largest share in 2023 and is expected to grow at a significant CAGR during the forecast period. The dominance of the companion animals segment is driven by the increasing adoption of pets, particularly dogs and cats, as family members, leading to a growing focus on their health and well-being. Pet owners are becoming more aware of digestive disorders like GERD and are willing to invest in advanced treatment options to improve their pets' quality of life.
North America is estimated to hold the largest animal gastroesophageal reflux disease market share over the forecast period.
North America is estimated to hold the largest animal gastroesophageal reflux disease market share over the forecast period. This high share is because of the growing prevalence of GERD in the region, and it is a common condition, especially in the dog population in the region. According to a study published by NIH, the prevalence of GERD in non-brachycephalic dogs in North America is 18.1 to 27.8%. GERD is also found in cats but less frequently than in dogs. In addition, developed veterinary care infrastructure, high pet adoption, and the presence of major market players such as Zoetis, and Elanco Animal Health in the US.
Asia-Pacific is predicted to have the fastest CAGR growth in the animal gastroesophageal reflux disease market over the forecast period. GERD in pets is increasingly recognized in Asia-Pacific countries, particularly in urban areas where pet ownership is rising. Further, the diverse dietary habits across Asia-Pacific countries can influence GERD in pets. For instance, high-carbohydrate diets common in some areas may contribute to obesity, a risk factor for GERD. However, awareness and diagnosis rates vary significantly across the region. Improved diagnostic tools such as endoscopy and imaging, along with effective pharmaceuticals, are enhancing the management of GERD in animals.
Company Profiling
Major key players in the animal gastroesophageal reflux disease market are McNeil Consumer Pharmaceuticals Co., Boehringer Ingelheim International GmbH., Zoetis Inc., Merck & Co., Inc., Elanco, Ceva, BioZyme, Inc., Annamaet Petfoods Inc., Hill's Pet Nutrition, Inc., Blue Buffalo Co., and Others.
Key Target Audience
Recent Development
Market Segment
This study forecasts global, regional, and country revenue from 2023 to 2033. Spherical Insights has segmented the animal gastroesophageal reflux disease market based on the below-mentioned segments:
Global Animal Gastroesophageal Reflux Disease Market, By Product
Global Animal Gastroesophageal Reflux Disease Market, By Animal
Global Animal Gastroesophageal Reflux Disease Market, By Regional Analysis
Apr 2025 - The Global Refinance Market Size is Expected to Grow from USD 20.31 Billion in 2023 to USD 47.27 Billion by 2033, at a CAGR 8.81% during the forecast period 2023-2033.
Apr 2025 - The Global Capital Exchange Ecosystem Market Size is Expected to Grow from USD 1.05 Trillion in 2023 to USD 1.79 Trillion by 2033, at a CAGR 5.48% during the forecast period 2023-2033.
Apr 2025 - The Global Stevia Market Size is Estimated to Grow from USD 504.68 Million in 2023 to USD 1396.79 Million by 2033, Growing at a CAGR of 10.72% during the forecast period 2023-2033.
We have received your message and would like to thank you for writing to us. If your inquiry is urgent, please use the telephone number listed below to talk to one of our staff members. Otherwise, we will reply by email as soon as possible.
+1 303 800 4326 +91 9561448932 emailsales@sphericalinsights.com
